MODE Trademark
Trademark Overview
On Tuesday, August 1, 2023, a trademark application was filed for MODE with the United States Patent and Trademark Office. The USPTO has given the MODE trademark a serial number of 98112146. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, April 2, 2024. This trademark is owned by Biohaven Therapeutics Ltd.. The MODE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical products, namely, multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders
Discovery in the nature of pharmaceutical research, development, engineering and testing, namely, for multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders
General Information
| Serial Number | 98112146 |
| Word Mark | MODE |
| Filing Date | Tuesday, August 1, 2023 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Tuesday, April 2, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 31, 2023 |
Trademark Statements
| Goods and Services | Pharmaceutical products, namely, multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders |
| Goods and Services | Discovery in the nature of pharmaceutical research, development, engineering and testing, namely, for multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, August 30, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, August 30, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Biohaven Therapeutics Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Road Town, Tortola VG1110
VG |
| Party Name | Biohaven Therapeutics Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Road Town, Tortola VG1110
VG |
Trademark Events
| Event Date | Event Description |
| Friday, August 4, 2023 | NEW APPLICATION ENTERED |
| Wednesday, August 30, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, September 23, 2023 | ASSIGNED TO EXAMINER |
| Monday, September 25, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 11, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 31, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 31, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, November 29, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, November 29, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, November 29, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, December 26, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, January 5, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, April 2, 2024 | SOU EXTENSION 1 GRANTED |
| Tuesday, April 2, 2024 | SOU EXTENSION 1 FILED |
| Tuesday, April 2, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, April 3, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, December 12, 2024 | SOU TEAS EXTENSION RECEIVED |
